Alloactivated Lyt 1 +2− T lymphoblasts bind syngeneic Ia antigens View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1980-06

AUTHORS

Bruce E. Elliott, Zoltan A. Nagy, Yinon Ben-Neriah, David Givol

ABSTRACT

A large proportion of T blasts activated in the mixed lymphocyte reaction (MLR) is capable of binding plasma membrane (PM) vesicles prepared from the stimulator strain1,2. The binding of vesicles is specific, and the antigens recognized are serologically detectable H–2K, D and I region products3,4. T blasts binding stimulator K (and D) antigens belong to the Lyt 1 −2+ subclass, whereas those binding stimulator Ia antigens are Lyt 1 +1− (ref. 5). We report here that antibodies against heavy chain V-region determinants (VH)6, and furthermore, monoclonal7 or conventional antibodies against responder cell Ia determinants strongly inhibit the binding of radiolabelled stimulator vesicles. Anti-responder Ia inhibition is restricted to the Lyt 1 +2− subset of T blasts and correlates with a weak expression of Ia determinants on these cells. The relevant Ia determinants are not resynthesized after trypsin treatment of the blasts. In these conditions anti-VH, but not anti-Ia reagents inhibit stimulator vesicle binding. Trypsinized T blasts can, however, passively absorb Ia material from supernatants of syngeneic, lipopolysaccharide (LPS)-activated spleen cells, and thus regain their susceptibility to vesicle-binding inhibition with anti-Ia sera. Acquisition of syngeneic Ia is also blocked by the anti-VH reagent. We conclude that Lyt 1 +2− MLR blasts possess binding sites for both allogeneic (stimulator) and syngeneic Ia antigens. More... »

PAGES

496-498

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/285496a0

DOI

http://dx.doi.org/10.1038/285496a0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1037300173

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/6447251


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Anti-Idiotypic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, Surface", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoglobulin Heavy Chains", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoglobulin Variable Region", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Isoantigens", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocyte Cooperation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocyte Culture Test, Mixed", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Major Histocompatibility Complex", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Antigen, T-Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "T-Lymphocytes", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cancer Research Division, Department of Pathology, Queen's University, Kingston, Ontario, Canada", 
          "id": "http://www.grid.ac/institutes/grid.410356.5", 
          "name": [
            "Cancer Research Division, Department of Pathology, Queen's University, Kingston, Ontario, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Elliott", 
        "givenName": "Bruce E.", 
        "id": "sg:person.0665151311.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0665151311.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Max-Planck-Institut f\u00fcr Biologie, Abteilung Immungenetik, T\u00fcbingen, FRG", 
          "id": "http://www.grid.ac/institutes/grid.419580.1", 
          "name": [
            "Max-Planck-Institut f\u00fcr Biologie, Abteilung Immungenetik, T\u00fcbingen, FRG"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nagy", 
        "givenName": "Zoltan A.", 
        "id": "sg:person.01257172275.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257172275.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Chemical Immunology, The Weizmann Institute of Science, Rehovot, Israel", 
          "id": "http://www.grid.ac/institutes/grid.13992.30", 
          "name": [
            "Department of Chemical Immunology, The Weizmann Institute of Science, Rehovot, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ben-Neriah", 
        "givenName": "Yinon", 
        "id": "sg:person.01123165765.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123165765.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Chemical Immunology, The Weizmann Institute of Science, Rehovot, Israel", 
          "id": "http://www.grid.ac/institutes/grid.13992.30", 
          "name": [
            "Department of Chemical Immunology, The Weizmann Institute of Science, Rehovot, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Givol", 
        "givenName": "David", 
        "id": "sg:person.01225647704.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225647704.57"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/256103a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008868104", 
          "https://doi.org/10.1038/256103a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01561454", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028401171", 
          "https://doi.org/10.1007/bf01561454"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/278056a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003723738", 
          "https://doi.org/10.1038/278056a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/248701a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021418039", 
          "https://doi.org/10.1038/248701a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/278555a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008794601", 
          "https://doi.org/10.1038/278555a0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1980-06", 
    "datePublishedReg": "1980-06-01", 
    "description": "A large proportion of T blasts activated in the mixed lymphocyte reaction (MLR) is capable of binding plasma membrane (PM) vesicles prepared from the stimulator strain1,2. The binding of vesicles is specific, and the antigens recognized are serologically detectable H\u20132K, D and I region products3,4. T blasts binding stimulator K (and D) antigens belong to the Lyt 1 \u22122+ subclass, whereas those binding stimulator Ia antigens are Lyt 1 +1\u2212 (ref. 5). We report here that antibodies against heavy chain V-region determinants (VH)6, and furthermore, monoclonal7 or conventional antibodies against responder cell Ia determinants strongly inhibit the binding of radiolabelled stimulator vesicles. Anti-responder Ia inhibition is restricted to the Lyt 1 +2\u2212 subset of T blasts and correlates with a weak expression of Ia determinants on these cells. The relevant Ia determinants are not resynthesized after trypsin treatment of the blasts. In these conditions anti-VH, but not anti-Ia reagents inhibit stimulator vesicle binding. Trypsinized T blasts can, however, passively absorb Ia material from supernatants of syngeneic, lipopolysaccharide (LPS)-activated spleen cells, and thus regain their susceptibility to vesicle-binding inhibition with anti-Ia sera. Acquisition of syngeneic Ia is also blocked by the anti-VH reagent. We conclude that Lyt 1 +2\u2212 MLR blasts possess binding sites for both allogeneic (stimulator) and syngeneic Ia antigens.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/285496a0", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1018957", 
        "issn": [
          "0028-0836", 
          "1476-4687"
        ], 
        "name": "Nature", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5765", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "285"
      }
    ], 
    "keywords": [
      "mixed lymphocyte reaction", 
      "Lyt-1", 
      "Ia determinants", 
      "syngeneic Ia", 
      "T blasts", 
      "Ia antigens", 
      "anti-Ia reagents", 
      "anti-Ia serum", 
      "lymphocyte reaction", 
      "Ia inhibition", 
      "spleen cells", 
      "antigen", 
      "K antigen", 
      "weak expression", 
      "antibodies", 
      "conventional antibodies", 
      "heavy chain", 
      "trypsin treatment", 
      "inhibition", 
      "binding of vesicles", 
      "large proportion", 
      "blasts", 
      "determinants", 
      "cells", 
      "IA", 
      "syngeneic", 
      "lipopolysaccharide", 
      "serum", 
      "stimulator", 
      "treatment", 
      "vesicles", 
      "binding", 
      "membrane vesicles", 
      "supernatant", 
      "correlates", 
      "expression", 
      "proportion", 
      "susceptibility", 
      "plasma membrane vesicles", 
      "subset", 
      "VH", 
      "subclasses", 
      "sites", 
      "vesicle binding", 
      "reagents", 
      "acquisition", 
      "reaction", 
      "conditions", 
      "materials", 
      "VH reagent", 
      "chain"
    ], 
    "name": "Alloactivated Lyt 1 +2\u2212 T lymphoblasts bind syngeneic Ia antigens", 
    "pagination": "496-498", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1037300173"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/285496a0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "6447251"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/285496a0", 
      "https://app.dimensions.ai/details/publication/pub.1037300173"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_176.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/285496a0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/285496a0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/285496a0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/285496a0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/285496a0'


 

This table displays all metadata directly associated to this object as RDF triples.

207 TRIPLES      21 PREDICATES      94 URIs      81 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/285496a0 schema:about N39907f6ba7c6476496c74b0e896ac36d
2 N4857edaabc1746729b5195cef6c62d9d
3 N6b6343698fe4469eb0e64af76cd15a03
4 N769b6a516c8c47678af878043dc463f5
5 N914e615a090f46ceb00b1c147d8551b5
6 N9defd4d751a5499da324ae3f8b6b0db6
7 Na95971393d78491c9e4ad10b7aabe455
8 Nb738df6ceb7940bd94ab614e588ed33d
9 Nc09d0b4d5ad94ea6a8181b4e1774d34e
10 Nd030422d71524923bdb14e8377f4fe18
11 Nd3b02e4f98634530bb07791ebbc9c9fc
12 Ne6ea49e2ed8040caafb1bfe68c23ab7b
13 anzsrc-for:11
14 anzsrc-for:1107
15 schema:author N8d6d039b1c794ea2a33d2640b6c62765
16 schema:citation sg:pub.10.1007/bf01561454
17 sg:pub.10.1038/248701a0
18 sg:pub.10.1038/256103a0
19 sg:pub.10.1038/278056a0
20 sg:pub.10.1038/278555a0
21 schema:datePublished 1980-06
22 schema:datePublishedReg 1980-06-01
23 schema:description A large proportion of T blasts activated in the mixed lymphocyte reaction (MLR) is capable of binding plasma membrane (PM) vesicles prepared from the stimulator strain1,2. The binding of vesicles is specific, and the antigens recognized are serologically detectable H–2K, D and I region products3,4. T blasts binding stimulator K (and D) antigens belong to the Lyt 1 −2+ subclass, whereas those binding stimulator Ia antigens are Lyt 1 +1− (ref. 5). We report here that antibodies against heavy chain V-region determinants (VH)6, and furthermore, monoclonal7 or conventional antibodies against responder cell Ia determinants strongly inhibit the binding of radiolabelled stimulator vesicles. Anti-responder Ia inhibition is restricted to the Lyt 1 +2− subset of T blasts and correlates with a weak expression of Ia determinants on these cells. The relevant Ia determinants are not resynthesized after trypsin treatment of the blasts. In these conditions anti-VH, but not anti-Ia reagents inhibit stimulator vesicle binding. Trypsinized T blasts can, however, passively absorb Ia material from supernatants of syngeneic, lipopolysaccharide (LPS)-activated spleen cells, and thus regain their susceptibility to vesicle-binding inhibition with anti-Ia sera. Acquisition of syngeneic Ia is also blocked by the anti-VH reagent. We conclude that Lyt 1 +2− MLR blasts possess binding sites for both allogeneic (stimulator) and syngeneic Ia antigens.
24 schema:genre article
25 schema:isAccessibleForFree false
26 schema:isPartOf N2e57c34e6f064ea4ae4690494ecb3280
27 N66501aad1a9e48ba99679a585aeb1151
28 sg:journal.1018957
29 schema:keywords IA
30 Ia antigens
31 Ia determinants
32 Ia inhibition
33 K antigen
34 Lyt-1
35 T blasts
36 VH
37 VH reagent
38 acquisition
39 anti-Ia reagents
40 anti-Ia serum
41 antibodies
42 antigen
43 binding
44 binding of vesicles
45 blasts
46 cells
47 chain
48 conditions
49 conventional antibodies
50 correlates
51 determinants
52 expression
53 heavy chain
54 inhibition
55 large proportion
56 lipopolysaccharide
57 lymphocyte reaction
58 materials
59 membrane vesicles
60 mixed lymphocyte reaction
61 plasma membrane vesicles
62 proportion
63 reaction
64 reagents
65 serum
66 sites
67 spleen cells
68 stimulator
69 subclasses
70 subset
71 supernatant
72 susceptibility
73 syngeneic
74 syngeneic Ia
75 treatment
76 trypsin treatment
77 vesicle binding
78 vesicles
79 weak expression
80 schema:name Alloactivated Lyt 1 +2− T lymphoblasts bind syngeneic Ia antigens
81 schema:pagination 496-498
82 schema:productId N7888a47e8add4fcc997b9fb83dff94ce
83 Na329552f5ba74854afaedb13f47a5269
84 Nb90c3781cc4e4a8d8e753ab00b1c4837
85 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037300173
86 https://doi.org/10.1038/285496a0
87 schema:sdDatePublished 2022-12-01T06:18
88 schema:sdLicense https://scigraph.springernature.com/explorer/license/
89 schema:sdPublisher N4da32a36e4c74fb583220f2c6e5d3f85
90 schema:url https://doi.org/10.1038/285496a0
91 sgo:license sg:explorer/license/
92 sgo:sdDataset articles
93 rdf:type schema:ScholarlyArticle
94 N2e57c34e6f064ea4ae4690494ecb3280 schema:volumeNumber 285
95 rdf:type schema:PublicationVolume
96 N39907f6ba7c6476496c74b0e896ac36d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Antigens, Surface
98 rdf:type schema:DefinedTerm
99 N4857edaabc1746729b5195cef6c62d9d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name T-Lymphocytes
101 rdf:type schema:DefinedTerm
102 N4da32a36e4c74fb583220f2c6e5d3f85 schema:name Springer Nature - SN SciGraph project
103 rdf:type schema:Organization
104 N66501aad1a9e48ba99679a585aeb1151 schema:issueNumber 5765
105 rdf:type schema:PublicationIssue
106 N6b6343698fe4469eb0e64af76cd15a03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Isoantigens
108 rdf:type schema:DefinedTerm
109 N769b6a516c8c47678af878043dc463f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Immunoglobulin Variable Region
111 rdf:type schema:DefinedTerm
112 N7888a47e8add4fcc997b9fb83dff94ce schema:name doi
113 schema:value 10.1038/285496a0
114 rdf:type schema:PropertyValue
115 N8d6d039b1c794ea2a33d2640b6c62765 rdf:first sg:person.0665151311.50
116 rdf:rest Nf237ef2086354006b6d9bdd185ab6c47
117 N914e615a090f46ceb00b1c147d8551b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Receptors, Antigen, T-Cell
119 rdf:type schema:DefinedTerm
120 N9defd4d751a5499da324ae3f8b6b0db6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Mice
122 rdf:type schema:DefinedTerm
123 N9ea42597cae04620a9d941b030c11c16 rdf:first sg:person.01123165765.15
124 rdf:rest Nf9f3e1ebdfc44d02a26e004aa2c98f65
125 Na329552f5ba74854afaedb13f47a5269 schema:name dimensions_id
126 schema:value pub.1037300173
127 rdf:type schema:PropertyValue
128 Na95971393d78491c9e4ad10b7aabe455 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Lymphocyte Cooperation
130 rdf:type schema:DefinedTerm
131 Nb738df6ceb7940bd94ab614e588ed33d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Lymphocyte Culture Test, Mixed
133 rdf:type schema:DefinedTerm
134 Nb90c3781cc4e4a8d8e753ab00b1c4837 schema:name pubmed_id
135 schema:value 6447251
136 rdf:type schema:PropertyValue
137 Nc09d0b4d5ad94ea6a8181b4e1774d34e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Antibodies, Anti-Idiotypic
139 rdf:type schema:DefinedTerm
140 Nd030422d71524923bdb14e8377f4fe18 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Immunoglobulin Heavy Chains
142 rdf:type schema:DefinedTerm
143 Nd3b02e4f98634530bb07791ebbc9c9fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Animals
145 rdf:type schema:DefinedTerm
146 Ne6ea49e2ed8040caafb1bfe68c23ab7b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Major Histocompatibility Complex
148 rdf:type schema:DefinedTerm
149 Nf237ef2086354006b6d9bdd185ab6c47 rdf:first sg:person.01257172275.55
150 rdf:rest N9ea42597cae04620a9d941b030c11c16
151 Nf9f3e1ebdfc44d02a26e004aa2c98f65 rdf:first sg:person.01225647704.57
152 rdf:rest rdf:nil
153 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
154 schema:name Medical and Health Sciences
155 rdf:type schema:DefinedTerm
156 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
157 schema:name Immunology
158 rdf:type schema:DefinedTerm
159 sg:journal.1018957 schema:issn 0028-0836
160 1476-4687
161 schema:name Nature
162 schema:publisher Springer Nature
163 rdf:type schema:Periodical
164 sg:person.01123165765.15 schema:affiliation grid-institutes:grid.13992.30
165 schema:familyName Ben-Neriah
166 schema:givenName Yinon
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123165765.15
168 rdf:type schema:Person
169 sg:person.01225647704.57 schema:affiliation grid-institutes:grid.13992.30
170 schema:familyName Givol
171 schema:givenName David
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225647704.57
173 rdf:type schema:Person
174 sg:person.01257172275.55 schema:affiliation grid-institutes:grid.419580.1
175 schema:familyName Nagy
176 schema:givenName Zoltan A.
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257172275.55
178 rdf:type schema:Person
179 sg:person.0665151311.50 schema:affiliation grid-institutes:grid.410356.5
180 schema:familyName Elliott
181 schema:givenName Bruce E.
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0665151311.50
183 rdf:type schema:Person
184 sg:pub.10.1007/bf01561454 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028401171
185 https://doi.org/10.1007/bf01561454
186 rdf:type schema:CreativeWork
187 sg:pub.10.1038/248701a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021418039
188 https://doi.org/10.1038/248701a0
189 rdf:type schema:CreativeWork
190 sg:pub.10.1038/256103a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008868104
191 https://doi.org/10.1038/256103a0
192 rdf:type schema:CreativeWork
193 sg:pub.10.1038/278056a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003723738
194 https://doi.org/10.1038/278056a0
195 rdf:type schema:CreativeWork
196 sg:pub.10.1038/278555a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008794601
197 https://doi.org/10.1038/278555a0
198 rdf:type schema:CreativeWork
199 grid-institutes:grid.13992.30 schema:alternateName Department of Chemical Immunology, The Weizmann Institute of Science, Rehovot, Israel
200 schema:name Department of Chemical Immunology, The Weizmann Institute of Science, Rehovot, Israel
201 rdf:type schema:Organization
202 grid-institutes:grid.410356.5 schema:alternateName Cancer Research Division, Department of Pathology, Queen's University, Kingston, Ontario, Canada
203 schema:name Cancer Research Division, Department of Pathology, Queen's University, Kingston, Ontario, Canada
204 rdf:type schema:Organization
205 grid-institutes:grid.419580.1 schema:alternateName Max-Planck-Institut für Biologie, Abteilung Immungenetik, Tübingen, FRG
206 schema:name Max-Planck-Institut für Biologie, Abteilung Immungenetik, Tübingen, FRG
207 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...